Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.85B |
| 2 |
Tesla
TSLA
|
+$1.78B |
| 3 |
Apple
AAPL
|
+$1.57B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.49B |
| 5 |
Mastercard
MA
|
+$1.09B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.3B |
| 2 |
Phillips 66
PSX
|
+$650M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$475M |
| 4 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$432M |
| 5 |
NRG Energy
NRG
|
+$387M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.59% |
| 2 | Financials | 9.21% |
| 3 | Consumer Discretionary | 7.33% |
| 4 | Healthcare | 5.59% |
| 5 | Communication Services | 5.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2976
CALL
Rapid7
RPD
$827M
| $1.14M | ﹤0.01% |
+43,100
| New | +$1.47M |
|
2977
Byline Bancorp
BY
$1.78B
| $1.14M | ﹤0.01% |
43,647
-19,323
| -31% | -$543K |
|
2978
Calumet Specialty Products
CLMT
$4.15B
| $1.13M | ﹤0.01% |
89,379
-5,574
| -6% | -$87.5K |
|
2979
Pennant Group
PNTG
$1.34B
| $1.13M | ﹤0.01% |
45,054
-15,016
| -25% | -$384K |
|
2980
Ooma
OOMA
$553M
| $1.13M | ﹤0.01% |
86,405
-13,486
| -14% | -$191K |
|
2981
ZTO Express
ZTO
$17.6B
| $1.13M | ﹤0.01% |
56,811
-222,910
| -80% | -$4.35M |
|
2982
PUT
Gates Industrial Corporation Ltd.
GTES
$7.05B
| $1.13M | ﹤0.01% |
+61,200
| New | +$1.26M |
|
|
CTO
2983
CTO Realty Growth
CTO
$819M
| $1.12M | ﹤0.01% |
58,147
-3,885
| -6% | -$75.4K |
|
2984
CALL
Biogen
BIIB
$30.9B
| $1.12M | ﹤0.01% |
8,200
-2,700
| -25% | -$386K |
|
2985
Ardagh Metal Packaging
AMBP
$3.02B
| $1.12M | ﹤0.01% |
370,565
-51,494
| -12% | -$145K |
|
|
PRSU
2986
Pursuit Attractions and Hospitality Inc
PRSU
$1.27B
| $1.12M | ﹤0.01% |
31,576
-31,562
| -50% | -$1.23M |
|
2987
First Advantage
FA
$3.61B
| $1.12M | ﹤0.01% |
79,284
-30,043
| -27% | -$505K |
|
2988
ProPetro Holding
PUMP
$1.42B
| $1.12M | ﹤0.01% |
151,866
-44,513
| -23% | -$387K |
|
2989
Hanmi Financial
HAFC
$956M
| $1.11M | ﹤0.01% |
49,177
-16,235
| -25% | -$376K |
|
2990
Rocket Pharmaceuticals
RCKT
$374M
| $1.11M | ﹤0.01% |
166,882
-67,070
| -29% | -$663K |
|
2991
CALL
WillScot Mobile Mini Holdings
WSC
$4B
| $1.11M | ﹤0.01% |
+40,000
| New | +$1.36M |
|
2992
PUT
Wolfspeed
WOLF
$1.64B
| $1.11M | ﹤0.01% |
363,100
+63,100
| +21% | +$369K |
|
2993
Protolabs
PRLB
$2.17B
| $1.11M | ﹤0.01% |
31,585
-12,808
| -29% | -$505K |
|
2994
BioLife Solutions
BLFS
$1.71B
| $1.11M | ﹤0.01% |
48,381
-17,754
| -27% | -$468K |
|
2995
Herbalife
HLF
$1.23B
| $1.1M | ﹤0.01% |
127,908
-50,771
| -28% | -$361K |
|
2996
Yext
YEXT
$574M
| $1.1M | ﹤0.01% |
179,068
-69,263
| -28% | -$448K |
|
2997
ImmunityBio
IBRX
$8.2B
| $1.1M | ﹤0.01% |
365,035
-31,449
| -8% | -$95.3K |
|
2998
Opendoor
OPEN
$3.54B
| $1.1M | ﹤0.01% |
1,110,313
-125,158
| -10% | -$164K |
|
2999
Napco Security Technologies
NSSC
$1.39B
| $1.09M | ﹤0.01% |
47,547
-17,598
| -27% | -$499K |
|
3000
PUT
Warby Parker
WRBY
$3.13B
| $1.09M | ﹤0.01% |
60,000
| – | – |
|
Similar funds
Barclays's Q1 2025 Portfolio in Review
As of Q1 2025, Barclays held 5,710 positions worth $353B, down 1.2% from $357B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Barclays deployed $16.5B of net new capital in Q1 2025, opening 439 new positions and adding to 1,449 existing holdings. Its largest new stake was JPMorgan BetaBuilders USD High Yield Corporate Bond ETF: 318,453 shares worth $14.7M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Honeywell, an estimated $1.3B trimmed.
- Barclays's largest Q1 2025 buy was JPMorgan BetaBuilders USD High Yield Corporate Bond ETF: 318,453 shares worth $14.7M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $3.85B increase.
- Barclays's biggest Q1 2025 reduction was Honeywell, cutting an estimated $1.3B.
- Barclays fully exited Smartsheet Inc. in Q1 2025, selling an estimated $45.7M.
- Barclays's ten largest holdings make up 37% of its $353B portfolio in Q1 2025.
- Barclays opened 439 new positions and closed 470 in Q1 2025.
- Barclays's portfolio value fell 1.2% quarter-over-quarter to $353B.
Based on Barclays's 13F filing for Q1 2025, filed 15 May 2025.